全文获取类型
收费全文 | 139176篇 |
免费 | 14990篇 |
国内免费 | 6260篇 |
专业分类
耳鼻咽喉 | 2149篇 |
儿科学 | 1472篇 |
妇产科学 | 1889篇 |
基础医学 | 14427篇 |
口腔科学 | 3412篇 |
临床医学 | 11089篇 |
内科学 | 19094篇 |
皮肤病学 | 2065篇 |
神经病学 | 371篇 |
特种医学 | 6205篇 |
外国民族医学 | 214篇 |
外科学 | 17597篇 |
综合类 | 25515篇 |
现状与发展 | 31篇 |
预防医学 | 4004篇 |
眼科学 | 415篇 |
药学 | 8734篇 |
51篇 | |
中国医学 | 3522篇 |
肿瘤学 | 38170篇 |
出版年
2024年 | 360篇 |
2023年 | 2276篇 |
2022年 | 4596篇 |
2021年 | 6168篇 |
2020年 | 5404篇 |
2019年 | 4742篇 |
2018年 | 4516篇 |
2017年 | 5291篇 |
2016年 | 5901篇 |
2015年 | 6566篇 |
2014年 | 9423篇 |
2013年 | 8630篇 |
2012年 | 8457篇 |
2011年 | 9145篇 |
2010年 | 7308篇 |
2009年 | 7079篇 |
2008年 | 7231篇 |
2007年 | 7666篇 |
2006年 | 7023篇 |
2005年 | 6241篇 |
2004年 | 4995篇 |
2003年 | 4291篇 |
2002年 | 3604篇 |
2001年 | 3386篇 |
2000年 | 2830篇 |
1999年 | 2245篇 |
1998年 | 2036篇 |
1997年 | 1897篇 |
1996年 | 1635篇 |
1995年 | 1352篇 |
1994年 | 1276篇 |
1993年 | 899篇 |
1992年 | 859篇 |
1991年 | 728篇 |
1990年 | 617篇 |
1989年 | 541篇 |
1988年 | 519篇 |
1987年 | 419篇 |
1986年 | 347篇 |
1985年 | 344篇 |
1984年 | 292篇 |
1983年 | 211篇 |
1982年 | 238篇 |
1981年 | 199篇 |
1980年 | 194篇 |
1979年 | 147篇 |
1978年 | 101篇 |
1977年 | 76篇 |
1976年 | 56篇 |
1975年 | 31篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
181.
HCC的早期诊断是其治疗的关键,HCC血清标志物的检测又为其诊断提供了有利的途径,并且操作简单,敏感性高和特异性强。目前常用的血清标志物为AFP、AFP变异体、AFP mRNA、AFU、GGT、DCP、AIF、GPC3等。这些标志物的联合使用有助于HCC的诊断及预后。 相似文献
182.
183.
184.
沙利度胺治疗肝癌的实验研究 总被引:1,自引:0,他引:1
目的研究沙利度胺对肝癌的治疗作用。方法采用小鼠肝癌移植性模型。观察沙利度胺对实体型和腹水型肿瘤的治疗作用。结果沙利度胺按每日200mg/kg连续给药10d,能明显抑制肝癌实体型肿瘤的生长,不降低小鼠血细胞数及淋巴细胞增殖;对腹水型肿瘤小鼠虽无明显生命延长作用,但沙利度胺与阿霉素联合用药对肝癌实体型及腹水型均有协调抗肿瘤作用,且可阻止阿霉素造成的小鼠血细胞减少、免疫功能降低。沙利度胺日剂量200mg/kg能明显增加肿瘤组织坏死,促进肿瘤组织边缘淋巴细胞侵润。结论沙利度胺对小鼠肝癌有确切治疗作用,与阿霉素联合用药效果更好。 相似文献
185.
B. Sorbe 《International journal of gynecological cancer》2004,14(5):788-793
In a large study on 1,220 patients with ovarian carcinoma in FIGO stages I-IV, the prognostic importance of the time factor for start of postoperative chemotherapy was studied together with other important factors for long-term survival. The patient series was a total geographic material of ovarian carcinoma patients treated during the years 1975-1993. All patients were followed up for 10 years or until death. The 5-year cancer-specific survival rate of the complete series was 50%. Significant and independent prognostic factors with regard to long-term cancer-specific survival were FIGO stage, histology, tumor grade, and completeness of the primary surgery. Special attention was paid to the prognostic importance of the time interval between primary surgery and the first course of chemotherapy. Patient groups with intervals shorter or longer than the median value were compared. In early-stage disease, no significant difference was noted. In advanced and bulky disease, an interval longer than the median value seemed to be beneficial compared with a shorter interval. However, after correction for other prognostic factors, the interval was not a significant factor (P = 0.647) with regard to the cancer-specific survival rate. Therefore, the time factor should not be an important argument for how to best organize the gynecologic oncology service. 相似文献
186.
187.
Su-Ping Sun Ye-Ning Jin Hong-Peng Yang Yi Wei Zhao Dong 《World journal of gastroenterology : WJG》2007,13(39)
AIM: To evaluate the relationship between changes in serum transforming growth factor β1 (TGFβ1) level and curative effect of radiotherapy (RT) in patients with esophageal carcinoma.METHODS: Ninety patients with histologically confirmed esophageal carcinoma were enrolled. Serum samples for TGFβ1 analysis were obtained before and at the end of RT. An enzyme-linked immunosorbent assay was used to measure serum TGFβ1 level. Multivariate analysis was performed to investigate the relationship between disease status and changes in serum TGFβ1 level.RESULTS: Serum TGFβ1 level in patients with esophageal carcinoma before RT was significantly higher than that in healthy controls (P < 0.001). At the end of RT, serum TGFβ1 level was decreased in 67.82% (59/87) of the patients. The overall survival rate at 1,3 and 5 years was 48.28% (42/87), 19.54% (17/87)and 12.64% (11/87), respectively. Main causes of death were local failure and regional lymph node metastasis.In patients whose serum TGFβ1 level decreased after RT,the survival rate at 1, 3 and 5 years was 61.02% (36/59),28.81% (17/59) and 18.64% (11/59), respectively. The survival rate at 1 year was 17.86% (5/28) in patients whose serum TGFβ1 level increased after RT, and all died within 18 mo (P < 0.01).CONCLUSION: Serum TGFβ1 level may be a useful marker for monitoring disease status after RT in patients with esophageal carcinoma. 相似文献
188.
目的 评价18F-脱氧葡萄糖(FDG)符合线路显像与异机CT图像融合诊断非小细胞肺癌(NSCLC)术后放化疗后复发转移的价值.方法 对可疑复发转移的40例NSCLC患者行18F-FDG符合线路显像,并于显像前后1周内行CT扫描.用三维(3D)图像融合软件进行图像融合.结果 在18F-FDG符合线路显像与CT扫描相同的范围内,40例患者共检出病灶58处,其中恶性52处,良性6处.融合图像诊断NSCLC复发转移的灵敏度、特异性、准确性、阳性预测值、阴性预测值、阳性似然比及阴性似然比分别为94.23%(49/52),5/6,93.10%(54/58),98.00%(49/50),5/8,5.65及0.07.图像融合灵敏度、准确性明显高于CT.单纯18F-FDG符合线路显像诊断效能与图像融合无差别,但与CT图像融合可明显提高对病灶的定位诊断(提高44.83%).结论 18F-FDG符合线路与CT图像融合诊断NSCLC术后放化疗后复发转移灵敏度高,定位准确,值得推广应用. 相似文献
189.
p21WAF1与p27KIP1真核双表达载体的构建鉴定及在胃癌细胞中的表达 总被引:1,自引:1,他引:0
目的 构建p21WAF1与p27KIP1真核双表达载体,体外转染胃癌7901细胞,观察其在胃癌细胞中的表达及相关特性.方法 提取人全血总RNA,利用逆转录-聚合酶链反应(RT-PCR)扩增p21WAF1和p27WAF1基因并将其分别克隆到真核双表达载体pIRES中构建重组质粒pIPES-p27KIP1-p21WAF1,经酶切和测序鉴定重组质粒.脂质体介导重组质粒plRES-p27KIP1.p21WAF1"转染胃癌7901细胞,收集并提取转染后12、24、48、72 h和5 d各细胞的总RNA,逆转录成cDNA,荧光定量聚合酶链反应(FQ-PCR)检测各细胞中p21WAF1和p27KIP1在RNA水平的表达.带有绿色荧光蛋白的pIRES-EGFP作为对照.结果 RT-PCR扩增分别获得约500和600 bp大小的产物,重组质粒pIRES-p27KIP1.p21WAF1经酶切和测序鉴定证实为p21WAF1和p27KIP1基因.转染胃癌7901细胞48 h时转染率为68%.与空质粒对照组比较,重组质粒转染胃癌7901细胞12、24、48、72 h和5 d后FQ-PCR证实p27KIP1的Ct值(cycle threshold,Ct)分别减少8.2、10、10、7.4和6.7,p21WAF1的Ct值分别减少7.4、8.2、8.2、6.3和5.70其中24 h和48 h的Ct值减少最大.结论 真核双表达载体pIRES-p27KIP1.p21WAF1构建成功并能在胃癌7901细胞内高效表达. 相似文献
190.
Ho-Seong Han Jai Young Cho Yoo-Seok Yoon 《Journal of hepato-biliary-pancreatic sciences》2009,16(4):427-432
Many studies have recently reported on laparoscopic liver resection, although its development has been slow compared to laparoscopy in other fields. The indications for the location of laparoscopic liver resection have previously been limited to easily accessible lesions. Performing laparoscopic liver resection in the posterior and superior parts of the liver has been considered difficult due to inadequate exposure, the poor operative field and the difficulty with parenchymal dissection. Flexible endoscopy, high definition imaging and various kinds of equipment for parenchymal transection have been introduced for clinical use. In addition, much experience with this procedure has been accumulated at many centers. Accordingly, there are an increasing number of reports on laparoscopic liver resection in difficult locations. At our institution, the location of the tumor is no longer a limitation to laparoscopic liver resection. However, for safer laparoscopic liver resection, the patient positioning and trocar placement should be individualized according to the tumor location. The type of resection also may depend on the remaining liver’s functional capacity. We describe here the technical considerations for performing laparoscopic liver resection, including the technical considerations for performing laparoscopic liver resection for lesions located in the postero-superior segments of the liver. 相似文献